Rossella Cirillo,Sandra Duperrier,Pathik Parekh,Mathilde Millot,Qin Li,Marie-Laure Thiolat,Micaela Morelli,Jing Xie,Didier Le Bars,Jérôme Redouté,Erwan Bezard,Véronique Sgambato

Abstract:Alterations of serotonin type 4 receptor levels are linked to mood disorders and cognitive deficits in several conditions. However, few studies have investigated 5-HT4R alterations in movement disorders. We wondered whether striatal 5-HT4R expression is altered in experimental parkinsonism. We used a brain bank tissue from a rat and a macaque model of Parkinson's disease (PD). We then investigated its in vivo PET imaging regulation in a cohort of macaques. Dopaminergic depletion increases striatal 5-HT4R in the two models, further augmented after dyskinesia-inducing L-Dopa. Pending confirmation in PD patients, the 5-HT4R might offer a therapeutic target for dampening PD's symptoms.

Striatal Serotonin 4 Receptor is Increased in Experimental Parkinsonism and Dyskinesia